Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer. - Wikidata - wikimedia - TriplyDB

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

http://www.wikidata.org/entity/Q36915205

about

Towards tumor immunodiagnostics Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer.Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.Immunotherapy biomarkers 2016: overcoming the barriers.The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies.Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer.Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma.PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1(+) and CD8(+) tumor-infiltrating T cells and outcome.PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter.Tumor lymphocytic infiltration in non-small cell lung cancer: the ultimate prognostic marker?Prognostic and predictive biomarkers post curative intent therapy.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer.Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA Q58736062 High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma

P2860

Q26738691-8FDD1EA6-B0CB-44A6-A846-64B3E337D7BA Q33607407-3726CC40-519B-483B-B7E9-9911000D304A Q33728267-0978768C-42FC-4E2F-B1EF-3BB9E2E0A2C8 Q36211993-A5CBF9C8-35FF-4E2F-A47D-FDDF78B68D69 Q36829208-B28411F0-B7C0-46C5-958D-EF151CDC28F1 Q37564046-0E512CFC-C95F-4D6E-A5B1-78734FBD090A Q37616487-07F0A8A1-9D90-43F5-9760-7464234739D7 Q37687671-0864C542-F55B-47C5-AEBE-9372EFCA185E Q37713070-02D1BD51-8DF5-4CE6-BAEC-9EC751996A79 Q37713438-1B48C45A-50E1-4C63-AC45-0888936FAEA8 Q38401891-06384CA8-D2F8-44BA-B07F-F4F4F75C9079 Q38878902-FF3DF177-EFF5-4FFB-8CE4-3527E50D2D75 Q39187442-5F5C4316-2C56-42A1-B685-D38F1AE20FB1 Q39293814-BBD2580A-0658-4EDB-8953-31DE7FB24932 Q39321608-11D5F97E-01EB-4695-9EAC-E3E016D7C665 Q39452745-01ADFD2C-F033-4DFF-8E61-E6DD0805038F Q40358673-92F92E69-F28F-44DE-B16B-9FD94D2E3176 Q40496586-D07C4CED-B7CB-4807-A6FD-03D599779EA2 Q41112503-DFE19A88-B0F5-4A8C-AFA2-38FE79969D48 Q42398706-4CD5A1B2-ECE9-4DD2-AC44-383658D4DA4C Q43026297-8FAFBBE5-D351-4E37-B266-28409CD6FCD6 Q46540302-993AE1A4-134F-4FD1-9574-DA75B402F966 Q46642782-9D00EB39-9B47-4A19-A183-D51DCCB1B27D Q47101079-E6501943-FAE7-42ED-B5A9-B0E0F7C4C653 Q47393395-1B6D6BAF-8113-4D47-9A67-0272F4FBFBAD Q47581436-1087164D-65A4-41C4-B927-EEACCBAF3303 Q48262038-84AAED54-9A02-443A-9428-75DE536817E5 Q55314488-6D6E628D-06C1-45B5-B139-427B90D15AFD Q55453667-0EA7F39C-F1AF-43B5-A9E4-AF0061F901A1 Q56892179-329265FF-2059-4B82-82DF-E4D23C6079D0 Q57191808-9C4DD454-7F9C-4C0F-B2D1-817A9787F0D3 Q58122079-4CDEBBFC-9BF1-47A4-B72D-BC166AD2887E Q58547850-EF34AF31-B81C-4ACF-B759-E54DF4988B98 Q58617557-4C0BB54A-50C7-4BB1-9680-3D576A6E9AF5 Q58736062-51A2E5D0-BB4C-46DD-A5FF-951B344A9751 Q58804465-D492C32F-4093-462E-95AF-DA09DA0F9B18

P2860

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

http://www.wikidata.org/entity/Q36915205

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic Effect of Tumor Lym ...... le Non-Small-Cell Lung Cancer.

@en

type

label

Prognostic Effect of Tumor Lym ...... le Non-Small-Cell Lung Cancer.

@en

prefLabel

Prognostic Effect of Tumor Lym ...... le Non-Small-Cell Lung Cancer.

@en

P1433

Q36915205-CAA0E149-0946-4580-AE8E-928809B32AF5

P1476

Q36915205-DAD79A5E-B3B3-4A6A-A3BC-91C35D8C8D7E

P2093

Q36915205-0379639F-AD6F-49E6-A6FF-144F3D45FC21

Q36915205-0D16BF45-0FD8-43B2-A727-9B04F77591A6

Q36915205-11EDBCCD-8B24-47E0-A78E-DFAF8A1D4E30

Q36915205-272D2B49-3833-4348-95D7-362E4CA9309F

Q36915205-5413D3F1-1454-4630-AEA8-D00668914078

Q36915205-C27AB225-F5A4-424C-B9DD-4A8AC080F5D6

Q36915205-CC0202BD-26F8-459E-A8AE-E490DE42EDCD

Q36915205-D6800EF0-38C1-4789-96D8-692CEBBD8444

Q36915205-DD6BFD49-EB11-4FC3-97A9-D416E87A8A8D

Q36915205-F20966DC-74B7-47EB-94CD-CF80B4812D90

P2860

Q36915205-0AD89017-ED8A-460A-B585-3319E8256730

Q36915205-0B489ACE-3D5A-420F-81E2-4DDE09CA9F7F

Q36915205-1437C991-06A3-465F-8142-B3BB1C92604E

Q36915205-1478F2EC-2372-4B2F-8188-2DD80516A1B3

Q36915205-309DCBEF-17A0-4190-887C-73DC4DD2AF11

Q36915205-30AF43F4-1191-4FCF-AB51-3E60D970506C

Q36915205-3578FD77-1855-41A5-B2C8-6524695F6EAF

Q36915205-3662DC10-C036-4321-95AC-3BBDE7457D25

Q36915205-428B2CFB-275F-47BB-83CA-A8952912962D

Q36915205-495811A7-F941-4578-87B2-CD72BE4EF8CA

P304

Q36915205-07C58A37-3F23-4A99-8155-84446C63BE5C

P31

Q36915205-AC1005BA-C404-4A40-9B0E-DEDF722597A2

P356

Q36915205-48B5E899-90CE-46E5-B3AC-F7FCDF9BC20C

P407

Q36915205-470711E0-22D6-43C0-80D6-1452B1810B6A

P433

Q36915205-D367B91D-8103-411A-8842-F1E4E1BA23B9

P478

Q36915205-AF668105-46FF-4016-9E4E-33F43CBD9D70

P50

Q36915205-35E78DF3-51A0-4C1A-8A1F-7A4D882DF52B

Q36915205-7660AF4C-0EFF-471F-8632-6B5B7D7E6EE3

Q36915205-7D3E9FC3-6002-4968-A22B-C5A114FFBDDB

Q36915205-957C5A50-B4D9-438C-8B45-4795602A48AC

Q36915205-E4DEA1F9-4787-4585-BF7F-50BCF733CC25

Q36915205-E710BFCF-3BAD-4ABF-A3C2-4B157749EBA0

Q36915205-FE6894E4-0AB0-404D-9C45-007103C385BA

P577

Q36915205-B28206CF-4CB7-4BB2-9FA3-4A7D7F7EEC57

P698

Q36915205-7EFF2831-1296-4384-BDB4-D2D440EFC5A7

P921

Q36915205-A42F8A20-AC70-417F-897D-BA408DF744A2

P932

Q36915205-E1E9C9B8-259A-4685-BB13-AC1E068C9223

P356

JCO.2015.63.0970

P1433

Journal of Clinical Oncology

P1476

Prognostic Effect of Tumor Lym ...... le Non-Small-Cell Lung Cancer.

@en

P2093

Ariane Dunant

http://www.w3.org/2001/XMLSchema#string

Frances A Shepherd

http://www.w3.org/2001/XMLSchema#string

Helmut Popper

http://www.w3.org/2001/XMLSchema#string

Lesley Seymour

http://www.w3.org/2001/XMLSchema#string

Martin Filipits

http://www.w3.org/2001/XMLSchema#string

Robert Kratzke

http://www.w3.org/2001/XMLSchema#string

Robert Pirker

http://www.w3.org/2001/XMLSchema#string

Sophie Marguet

http://www.w3.org/2001/XMLSchema#string

Stephen Graziano

http://www.w3.org/2001/XMLSchema#string

Sylvie Lantuejoul

http://www.w3.org/2001/XMLSchema#string

P2860

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Cancer immunoediting: from immunosurveillance to tumor escape

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

External validation of multivariable prediction models: a systematic review of methodological conduct and reporting

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Effector memory T cells, early metastasis, and survival in colorectal cancer.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

P304

1223-1230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.63.0970

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Charles Soria

Thierry Le Chevalier

Gwénaël Le Teuff

Ming-Sound Tsao

Elisabeth Brambilla

Jean-Yves Douillard

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26834066

http://www.w3.org/2001/XMLSchema#string

P921

P932

4872323

http://www.w3.org/2001/XMLSchema#string